47
Celebrating the Fifth Anniversary of the America Invents Act: Successes, Failures, and Room for More Growth Janet Gongola, Senior Advisor Office of the Under Secretary and Director [email protected] Direct dial: 571-272-8734

Celebrating the Fifth Anniversary of the America Invents Act: Successes, Failures, and Room for More Growth-Janet Gongola, USPTO

Embed Size (px)

Citation preview

Celebrating the Fifth

Anniversary of the America

Invents Act: Successes, Failures,

and Room for More Growth Janet Gongola, Senior Advisor

Office of the Under Secretary and Director

[email protected]

Direct dial: 571-272-8734

Overview

• Patent Quality

• AIA Trial Proceedings

• Big & Open Data

2

Enhanced Patent Quality

Initiative

3

Patent Application Inventory (Data from FY 2011 through July 25, 2016)

4

First Action Pendency and Total Pendency (Data from FY 2011 through June 2016)

5

Enhanced Patent Quality Initiative

• What is a high quality patent?

• What changes will practitioners see?

6

4 Categories of Enhanced Patent Quality

• Search Enhancements

• Prosecution Enhancements

• Post-Examination Enhancements

• Evaluation of Examination

7

Search Enhancements

• Global Dossier

• Prior Art Roundtable

8

Global Dossier: Office Action Access

9

Global Dossier: Document Filtering

10

Prior Art Roundtable

• Two topics: – Obtaining prior art from Global Dossier for foreign counterpart

applications and from U.S. dockets for parent/child applications; and

– Printing prior art on issued patents

• September 28, 2016 at USPTO in Alexandria, VA

• Comments due by October 28, 2016 to [email protected]

11

Prosecution Enhancements

• Post Prosecution Pilot—started on July 11,

2016

• Petitions Timeline

• Cancer Moonshot—started June 29, 2016

12

Post Prosecution Pilot (Data as of August 29, 2016)

13

Petitions Timeline http://www.uspto.gov/patents-application-process/petitions/timeline/patents-petitions-

timeline#step1

14

Petitions Timeline Example

15

Cancer Moonshot (aka Patents for Patients) • Free, fast track examination for patent applications related to cancer

treatment

• Available to any applicant including early stage bio-tech companies, universities, large pharmaceutical companies, and entities with a products in FDA approved clinical trials

• Also available if applications is already on file with the USPTO

• Started in June 29, 2016 and will run for 1 year

• Goal is to complete examination within 1 year of application filing

16

Post Examination Enhancements

• Post Grant Outcomes Pilot—closed on

August 15, 2016

• Design Patent Publication Improvements

17

Post Grant Outcomes Pilot

18

Post Grant Outcome: Survey

• In the Office Action of the child case, did the examiner refer

to any of the references cited in the AIA trial petition of the

parent?

19

Post Grant Outcome: Survey

• If the examiner did not use any references cited in the AIA

trial petition, why not?

20

Post Grant Outcome: Survey

• How did the examiner apply the AIA trial reference(s) in the

child application?

21

Post Grant Outcome: Survey

• Did the examiner consider any other documents submitted

with the petition, e.g., expert declaration(s)?

22

Design Patent Printing

23

Evaluation of Examination

• Topic Submission for Study

• Revised review process for examiner’s

work product

24

Case Study Topics

• 35 U.S.C. 101

– Deviation of 35 U.S.C. §101 rejections from official guidance and

correctness/completeness of rejections and e analysis

– Consistency of the application of 35 U.S.C. §101 across art units/technology centers

– Practice of compact prosecution when 35 U.S.C. §101 rejections are made

• Correctness and clarity of motivation statements in 35 U.S.C. §103 rejections

• 35 U.S.C. 112

– Enforcement of 35 U.S.C. §112(a) written description in continuing applications

– Consistent treatment of claims under 35 U.S.C. §112(f)

25

Master Review Form http://www.uspto.gov/sites/default/files/documents/MRF%20-

%20IQS%20Version%2020160226%20-%20Final.pdf

26

Master Review Form Example

27

AIA Trial Proceedings

28

29

30

31

32

33

34

Cuozzo v. Lee

• PTAB may construe claims in an issued

patent according to their broadest

reasonable interpretation

• PTAB’s decision whether to institute an IPR

proceeding is judicially unreviewable

35

36

37

38

39

New Final Rules

• Published on April 1, 2016; effective on

May 2, 2016

• Major rule changes:

– Patent owner preliminary response

– Claim construction for expired patents

40

Big & Open Data

41

PatentsView https://www.commerce.gov/media/photo/patentsview-screenshotjpg

42

Assignment Database http://assignment.uspto.gov/

43

Open Data Portal https://developer.uspto.gov/

44

Example: U.S. v. Foreign Filings

45

Questions?

Janet Gongola, Senior Advisor

Office of the Under Secretary and Director

[email protected]

Direct dial: 571-272-8734